Godrej Agrovet:
₹2,718 Cr Revenue. Five Businesses
Quietly Turning Around. What’s The Catch?
Animal feed printing money. Oil palm at all-time extraction high. Astec finally profitable. Dairy finding feet. Poultry dumping live birds for brands. Stock down 20% in a year anyway. Welcome to agribusiness.
The Multi-Headed Beast That Eats Well, Digests Slowly
- 52-Week High/Low₹876 / ₹506
- Q3 Revenue₹2,718 Cr
- Q3 PAT₹110 Cr
- Q3 EPS5.97
- TTM EPS₹22.81
- Book Value₹94.1
- P/B Ratio6.08x
- Dividend Yield1.89%
- Debt/Equity1.19x
- 9M Growth+9% YoY
A Company Trying To Be Five Companies At Once
Godrej Agrovet is what happens when a conglomerate’s agriculture arm gets tired of boring. ₹11,000 crore market cap spread across five verticals: animal feed (47%), oil/palm (14%), dairy (17%), crop protection (13%), poultry (9%). Each operates like a mini-company with different economics, customers, margins.
Most are firing simultaneously now. Feed scales volumes. Oil palm optimizes extraction. Dairy fixes GTM. Astec exits losses. Poultry sheds commodity. But managing five distinct businesses while one balance sheet? Something’s usually on fire somewhere. New MD: Sunil Kataria took charge Sept 2025 (five-year tenure), ending Balram Yadav’s 19-year run. Creamline acquired at 99.32% ownership (May 2025). Three ₹180+ Cr capex MoUs signed. Management completing “deep strategy work” to decide which businesses get growth capital, which get de-prioritized — decisions coming April 2026. Portfolio restructuring incoming. The question: will stock care?
Five Divisions, Zero Single Story, Maximum Confusion
Animal Feed (47%): India’s #2 compound feed. Cattle, broiler, layer, fish, shrimp. Q3 volumes +12% YoY; cattle +21%. Cattle is highest margin (brandable, premiumizable). Mix shift towards cattle = margin accretive even if blended looks flat. Why cattle accelerating? Farmers upgrade from unbranded when milk realizations improve. Margin lever: 2,020 per MT in Q3 vs 1,937 last year — operational efficiency + mix power.
Vegetable Oil (14%): 30% market share, largest processor. 200,000 hectares plantation potential. Q3: FFB +16%, OER 21% (all-time high). PKO sticky pricing (coconut supply constrained globally). Heavy capex: CPO refinery “2 months,” downstream refinery “Q1 FY27.” Value-added ~8% now; post-capex expected to “gallop rapidly.” Long-term FFB CAGR: 12-15%.
Dairy (17%): Creamline, now 99.32% owned (May 2025). South India across 5 states. VAP: 35-37%. Headwind: milk inflation (global butter exports). Tailwind: consultant work absorbed ~10% inflation. Real lever: GTM strategy — distribution, routes-to-market. Takes “several quarters.” Q3 only +3% YoY growth — company being patient.
Crop Protection (13%): 6,600+ distributors. Q3 revenue +37% but earnings flat (unseasonal rains, cyclones, crop damage). Lumpy. Q4 has “base effect” headwind. Ex that, management sees “very healthy” growth. Portfolio 60-65% in-house + in-licensed (higher margin). New launches: Ashitaka (maize, “very positive”), Takai (multi-crop, launching March). Strategic shift: away from single-molecule dependence to diversified pipeline. Target: 28-30% EBITDA margin.
Poultry (9%): Godrej Foods + Godrej Tyson JV. Live bird exposure being starved. Strategy: pure-play branded retail. Real Good Chicken + Yummiez future. Yummiez went 15%→30% share recently. Q3 EBITDA ₹17 Cr (+51% YoY), 8% margin. End-game: dump commodity, build protein brand. Pet food plant “month or so.”
Q3 FY26: The Quarterly Play
Quarterly Results | Q3 EPS: ₹5.97 | Annualised (Q3×4): ₹23.88 | Full-year TTM EPS: ₹22.81
Source table
| Metric (₹ Cr) | Q3 FY26 | Q3 FY25 | Q2 FY26 | YoY % | QoQ % |
|---|---|---|---|---|---|
| Revenue | 2,718 | 2,450 | 2,567 | +11.0% | +5.9% |
| Op Profit | 242 | 220 | 213 | +10.0% | +13.6% |
| OPM % | 9% | 9% | 8% | Flat | +100 bps |
| PAT | 110 | 110 | 84 | Flat | +31.0% |
| EPS (₹) | 5.97 | 5.80 | 4.81 | +2.9% | +24.1% |
What’s This Diversified Mess Worth?
Method 1: P/E
TTM EPS ₹22.81. Sector P/E 25.7x. Godrej ROCE 16.6% (vs 18-20% sector), justify discount. Fair P/E: 20x–24x.
₹456 – ₹547
Method 2: EV/EBITDA
TTM EBITDA ~₹900 Cr (9% × ₹10,034 Cr sales). EV ₹13,201 Cr = 14.7x. Sector 12x–18x. Godrej 13x–15x band justified.
₹435 – ₹504
Method 3: Sum-of-Parts
Feed: 20x × ₹350 Cr = ₹7,000 Cr. Oil: 16x × ₹140 Cr = ₹2,240 Cr. Dairy: 18x × ₹68 Cr = ₹1,224 Cr. Crop: 15x × ₹100 Cr = ₹1,500 Cr. Poultry: 14x × ₹50 Cr = ₹700 Cr. Total ≈₹12,600 Cr ÷ 19.2 Cr shares.
₹480 – ₹540
The Godrej Agrovet Reconstruction Tour
🔴 Portfolio Restructuring Incoming
Management completed “deep strategy work” starting ~2 months before Feb concall. Expects to communicate “towards early April” with “clear sharp choices” on which businesses get priority investment, which get de-prioritized. Market attractiveness + right-to-win filtering. Mid-term profitability + ROCE filters. Structural calls (demerger? spin-off? stake sales?) follow later. Translation: Godrej is auditioning portfolio in real-time. Some business might get dumped. Some might get a billion rupees. Stock hates surprises about portfolio structure — watch for volatility.
✅ Capex MoUs Signed
- Dec 2025: Creamline ₹150 Cr (40-acre Telangana plant)
- Nov 2025: ₹70 Cr (dairy + oil palm, AP)
- Sep 2025: ₹960 Cr (MoFPI food-processing, 5 states, FY27)
- Oil CPO plant: 2 months. Refinery: Q1 FY27.
⚠️ Management Transition
- Sunil Kataria: MD & CEO from Sept 2025 (5-year tenure)
- Balram Yadav: Superannuated after 19-year run (Aug 2025)
- Leadership vacuum during restructuring — execution risk watch
- Creamline acquisition (99.32%) integration ongoing
Leverage Rising. Debt Spiking. Capex Party Getting Expensive.
Source table
| Item (₹ Cr) | FY24 | FY25 | Sep 2025 (Latest) |
|---|---|---|---|
| Total Assets | 5,667 | 5,505 | 6,105 |
| Net Worth | 2,516 | 2,381 | 1,810 |
| Borrowings | 1,416 | 1,396 | 2,159 |
| Other Liabilities | 1,734 | 1,729 | 2,136 |
| Total Liabilities | 5,667 | 5,505 | 6,105 |
Borrowings ₹1,396 Cr → ₹2,159 Cr in 4 months. +54% increase. Creamline acquisition + oil capex + dairy expansion = financing party. D/E: 1.19x (up from 0.55x). Interest coverage: 5.32x (compressed but healthy).
Dropped to ₹1,810 Cr from ₹2,381 Cr. Capex + acquisitions deployment. Productive use, but equity base tightening. Borrowing capacity being used. If capex ROI disappoints, leverage bites.
Jumped ₹1,729 → ₹2,136 Cr. Mostly trade payables + deferred revenue. Shows WC tied up in growth. Not alarming, but growth-dependent.
Building. But At What Cost?
Source table
| Cash Flow (₹ Cr) | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Operating CF | +610 | +874 | +678 | +969 |
| Investing CF | -380 | -284 | -327 | -82 |
| Financing CF | -220 | -594 | -328 | -901 |
| Net CF | +10 | -5 | +23 | -13 |
₹969 Cr FY25, up from ₹678 FY24. Business printing cash. If OpCF stays positive, company funds growth + dividends.
-₹82 Cr FY25 vs -₹327 FY24. But Sep 2025 likely shows higher capex. Refinery + dairy capex deploying now.
Dividends ~₹250 Cr. Debt repayment negligible (actually debt raised post-Sep for capex). Returning cash while borrowing. Sustainable if OpCF growth persists, risky if earnings stall.
Godrej in “growth + return capital” mode. If refinery/dairy capex converts to earnings (12-18 months), leverage compresses, OpCF accelerates, stock re-rates. If capex disappoints, leverage becomes millstone.
Profitable. Leveraging. Executing.
The Slow Grind. For Now.
Source table
| Metric (₹ Cr) | FY22 | FY23 | FY24 | TTM |
|---|---|---|---|---|
| Sales | 8,306 | 9,374 | 9,561 | 10,034 |
| EBITDA | 772 | 848 | 918 | 871 |
| EBITDA % | 9.3% | 9.1% | 9.6% | 8.7% |
| PAT | 419 | 295 | 359 | 409 |
| EPS | 20.96 | 15.71 | 18.71 | 22.81 |
The FY23 Dip: Godrej took hit in FY23 (PAT fell to ₹295 Cr) — likely Astec losses, Crop weakness, disruptions. FY24 recovered (₹359 Cr). TTM shows strong EPS growth ₹22.81 (+21.9% vs FY24 ₹18.71). Turnaround narrative. But revenue growth pedestrian at 4-5% CAGR. Earnings expansion from margin recovery (Astec, Poultry) + mix (Feed, Oil). Quality turnarounds don’t look hypergrowth — look like this.
Godrej vs The Fragmented Mess
Source table
| Company | Q Rev (₹ Cr) | Q PAT (₹ Cr) | P/E | ROCE % |
|---|---|---|---|---|
| Godrej Agrovet | 2,718 | 110 | 23.9x | 16.6% |
| Avanti Feeds | 1,384 | 163 | 26.2x | 24.0% |
| Mukka Proteins | 654 | 27 | 14.7x | 11.6% |
| Mayank Cattle Feed | 185 | 3 | 15.8x | 16.5% |
Peer median P/E 25.7x. Godrej 23.9x (slightly below). But Avanti Feeds (pure feed) at 26.2x with 24% ROCE — Godrej’s diversification = ROCE drag on valuation. Godrej’s challenge: proving diversification worth the discount.
Godrej Industries Owns 64.8%. Rest Is Retail. Clean Pledge.
Promoter: Godrej Industries Limited
Godrej Industries (AA+ rated ICRA) holds 64.84%. Diversified into oleo chemicals, real estate, now agriculture. Zero pledges, clean balance sheet at holding level. Fortress-like promoter. Downside: GIL’s own leverage might constrain Agrovet capex/dividend if GIL needs capital.
Shareholding Pattern
Promoters 64.8% | Public 20.7% | DIIs 5.4% (LIC 1.21%) | FIIs 6.3% | Pledge 0.00%. Shareholders: 1.16 lakh. Retail India watching.
Clean. But Restructuring In Progress.
✅ Governance Strengths
- ✓ Zero pledges — clean holding
- ✓ Clean audit history — no material qualifications
- ✓ Regular concalls + investor engagement
- ✓ ICRA AA- (Negative) — solid credit
- ✓ Promoter AA+ rated — fortress balance sheet
- ✓ 5-year MD tenure locked (Kataria 2025-2030)
⚠️ Governance Watch
- ⚠ SEBI warning for late Astec disclosures (Sept 2025)
- ⚠ Leadership transition during restructuring
- ⚠ Portfolio restructuring in flight — April decisions
- ⚠ Debt +54% in 4 months — capex financing
- ⚠ D/E doubled to 1.19x — leverage risk if earnings disappoint
- ⚠ Creamline 99.32% — further centralization
Agribusiness: Monsoons Decide. PEs Pretend They Know Better.
India’s agriculture: subsistence farming vs corporate agribusiness, commodity volatility vs branded premiumization, weather gods deciding outcomes faster than boards can. Feed consolidating (Godrej, Avanti, Cargill). Oil palm becoming land-grab + efficiency game. Dairy CPO-dominated (margins = milk negotiation). Crop protection commoditizing (China competition). Poultry oscillating (live margin compression vs branded retail).
🌾 The Tailwinds
Milk protein consumption rising. Branded feed adoption growing (farmers upgrading for better yields). Organised poultry replacing unregulated slaughter. Govt focus on food security = capex cycle. Monsoons better 2025. Land lease models allow oil palm acreage without ownership capex.
🔥 The Headwinds
Milk inflation (global butter exports). CPO prices under pressure (soft oils glut). Crop Protection lumpy (unseasonal rains, Godrej grape damage Q3). Chinese agrochemicals flooding markets (pricing pressure). EV penetration (lower oil/vehicle). Commodity volatility (base oil, CPO/PKO, feed ingredients). Land acquisition bottlenecks (oil palm).
🎲 The Wildcards
Policy: Govt tariffs/subsidies for domestic oil palm? Climate: La Niña/El Niño monsoons. FX: INR depreciation. Competition: Global feed majors stepping up India. Consolidation: M&A in dairy + poultry. Demerger: Will Godrej spin off high-ROCE business? Happening Q2 FY27 onwards.
Sector Narrative: Feed best economics (branded, sticky, 16%+ margins). Oil palm has optionality (refinery capex). Dairy slow grind (milk inflation, GTM heavy). Crop protection under pressure but margin improvement possible. Poultry portfolio-building (commodity → branded). Question: Can Godrej make five bets simultaneously? Or needs to jettison 2-3 for winners?
The Godrej Agrovet Puzzle
Godrej Agrovet is a collection of five half-baked business ideas that, when they work, generate solid cash flows and reasonable returns. Animal feed branded and sticky. Oil palm leveraged to productivity + extraction. Dairy fixing GTM. Astec profitable. Poultry ditching commodity. Yet stock trades 23.9x P/E with 16.6% ROCE, and management about to announce portfolio restructuring. Earnings turnaround real. Valuation fair at best, expensive at worst. April strategy day is make-or-break.
Q3 FY26 Execution: Revenue +11% YoY (₹2,718 Cr). PBT +23% on margin expansion + operational magic. OPM steady 9% (in guidance). EPS flat YoY (₹5.97) but +24% QoQ (Q2 rebound). Annualised EPS ₹23.88 vs TTM ₹22.81 — slight acceleration. Execution, not hypergrowth. In agribusiness, steady compounds. Issue: stock down 20% in a year despite this. Patience unrewarded.
The Leverage Gamble: Debt doubled to ₹2,159 Cr (₹1,396 FY25). D/E 1.19x (0.55x FY25). Financing refinery, dairy, Creamline. If capex converts 15%+ returns in 2 years, leverage compresses + stock re-rates. If capex disappoints, leverage millstone. April should clarify ROI timelines.
Historical (5y): Stock delivered ~3.9% CAGR, massively underperforming market. Dividend 1.89% (so total return minimal). Company restructuring (divesting, acquiring Creamline, Astec losses) while stock drifted sideways. Classic conglomerate-restructuring price action. Patience tested. Once restructuring announced (April), optionality unlocks.
✓ Strengths
- Feed: 47% rev, branded, 16%+ margins, cattle +21% YoY
- Oil: 30% share, refinery unlocking VAP (8%→15%+ potential)
- Astec: CDMO turnaround real, inquiry funnel doubled, superior margin
- Dairy: 99.32% owned, ₹220 Cr capex MoUs, regional strength
- Poultry: commodity→branded retail (8%+ margin target)
- OpCF: ₹969 Cr FY25, +43% vs FY24
✗ Weaknesses
- Revenue growth slow: 4-5% CAGR (not compelling)
- ROCE below sector: 16.6% vs 18-20% median (diversity drag)
- Leverage spiked: D/E 1.19x, interest coverage 5.3x (execution-dependent)
- Restructuring risk: April could trigger volatility
- Dairy GTM challenge: +3% Q3 growth (still below target)
- Commodity exposure: oil (CPO/PKO), crop (ingredients)
→ Opportunities
- Oil refinery: Q1 FY27, VAP could add 10-15 Cr+ EBITDA
- Dairy capex: ₹220 Cr MoUs, geographic scaling
- Astec CDMO: China+1 tailwind, 1.5x enterprise margin
- Feed rural: 40,000 outlets, cattle mix upside
- Restructuring: spin-off potential (if highest-ROCE separated)
- Poultry: affordable protein category creation
⚡ Threats
- Leverage execution: if refinery/dairy ROI disappoints, D/E stays elevated
- Milk inflation: global butter pressure may last beyond Q4
- Crop Protection: unseasonal weather lumpy, base effect Q4
- China pricing: agrochemical overproduction (pressure “flattened” not solved)
- Poultry scale: live bird depreciation ongoing, Yummiez growth not visible in topline yet
- Restructuring volatility: April announcement could tank stock pre-event
Godrej Agrovet is a company in transition, executing competently while restructuring simultaneously.
Earnings turnaround real (PAT +21.9% YoY TTM). Margins improving. Capex deployed productively. Leverage spiked but manageable — OpCF covers it. Stock fair at 23.9x P/E if restructuring creates optionality. Overvalued if leverage becomes drag. April strategy day = moment of truth. Compelling spin-off announcement = stock re-rates. Punt or disappoint = 10-15% correction. Fair value range ₹430–₹550 reflects “wait and see” posture. CMP ₹575 = betting April news is good. Patience required. Most investors don’t have it.